COMPUTEX
31.5.2021 08:31:06 CEST | Business Wire | Press release
COMPUTEX kicked off this year’s month-long #COMPUTEXVirtual on May 31 with James Huang, TAITRA Chairman, highlighting the not-to-be-missed events. Michelle Johnston Holthaus, Intel Executive Vice President, Chief Revenue Officer, discussed accelerating digital transformation and how to release a new era of innovation when the world is most looking forward to innovation. On the same day, Arm CEO Simon Segars discussed the role of technology in the post-pandemic. Using examples from Arm's ecosystem partners, Segars demonstrated how technology could be a remarkable force for good that will be critical to the world’s recovery and create a more sustainable and secure future. Breaking away from traditions, COMPUTEX 2021 Virtual is an all-virtual exhibition, using AI platforms and leading the way to create a prosperous technology ecosystem.
“COMPUTEX was born in the 1980s when the technology industry took off. At that time, together with entrepreneurs from around the world, Taiwan pursued disruptive innovation and created an industry supply chain that paved the way for the Internet and digital economy that we have today. It has been one year into the pandemic, and we continue to push forward with innovation and navigate in the new normal. As Taiwan stands at the center of the global technology ecosystem, we will never cease to build, connect, integrate, innovate, and push forward with the latest technologies. Today, I am honored to announce the opening of #COMPUTEXVirtual. No matter where we are, let COMPUTEX connect us for a better future,” said James Huang, TAITRA Chairman.
COMPUTEX 2021 Opening Keynote by Intel is led by Executive Vice President and Chief Revenue Officer Michelle Johnston Holthaus with the theme of "Innovation Unleashed". Intel talks about sustainability awareness of enterprises under the raging global pandemic and how we continue to work with global partners to promote digital transformation; Intel not only response to the global market demand quickly and flexibly with the IDM 2.0 business model, but it also continues to promote innovation with 5G and its Open Architecture. We will also unveil new products leading in performance and enrich people’s user experience.
Arm CEO Simon Segars’ keynote titled “Sparking the World’s Post-Pandemic Recovery” demonstrated how technology can be a remarkable force for good that will be critical to the world’s recovery and create a more sustainable and secure future. The combination of computing in the age of AI will accelerate how we tackle complex challenges surrounding climate change, security, and equitable access to technologies and connectivity. Segars indicated that long-term investments in research and development are the key to shaping that future. Arm has invested significant resources in its next-generation architecture. Armv9 will enable partners to solve hard problems in the next decade of compute related to security, compute efficiency, and AI-enabled services, all while fighting climate change at the same time.
A Variety of Events for an All-New Virtual Experience
COMPUTEX 2021 Virtual offers live demonstration of the latest solutions on 5G, AI & IoT, Edge Computing, High-Performance Computing (HPC), Gaming, and Innovations and Startups.
The month-long online exhibition also includes a variety of events, including the #COMPUTEXVirtual online exhibition, COMPUTEX CEO Keynote, COMPUTEX Keynote, COMPUTEX & InnoVEX Forum, and COMPUTEX Matchmaking, giving attendees direct access to the leading tech manufacturers and the latest technology trends. The exhibition also enables the exhibitors to effectively seize business opportunities through the online matchmaking platform.
The #COMPUTEXVirtual online exhibition features Tech Insights, Virtual Displays, Matchmaking and Networking, and Hyper-Personalized Recommendations. #InnoVEXVirtual, the exclusive exhibit for startups, offers vibrant synergy on the other hand. #COMPUTEXVirtual is now open until June 30 midnight. Register now for free at: https://virtual.computextaipei.com.tw/
For more updates:
COMPUTEX website: https://www.computextaipei.com.tw/
InnoVEX website : https://www.innovex.com.tw/
About COMPUTEX TAIPEI (also called COMPUTEX):
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual:
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX, Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnoVEXVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
About TAITRA:
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210530005044/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom